In May 2025, Novo Nordisk submitted this new dose for FDA review
And the 12 mg/0.1 mg for maintenance or higher-dose protocols
5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels [1] [2]
Since retatrutide protocols involve drawing from the same vial over multiple weeks, bacteriostatic water is the correct and safer choice
BPC-157 Dosage Protocol: The Exact Schedule We Follow The standard BPC-157 dosage range for subcutaneous injection is 250 to 500 mcg once or twice daily, administered near the target injury site, over a cycle of four to six weeks
Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes